BIVALIRUDIN FOR INJECTION
Google image searchProduct monograph
Active ingredient
bivalirudin, 250 MG/VIAL
DIN: 02435268
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL. 50MG/ML RECONSTITUTED
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 23-APR-2019
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AE — Direct thrombin inhibitors (ATC, ATC/DDD)
- B01AE06 — BIVALIRUDIN (ATC/DDD)
Reference brand drug: Angiomax
